Overview

A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy of the study drug known as duloxetine in participants with chronic osteoarthritis (OA) and knee pain in Japan.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Shionogi
Treatments:
Duloxetine Hydrochloride